New drug combo targets tough staph blood infections
NCT ID NCT05184764
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tested a new medicine called AP-SA02, given alongside standard antibiotics, for adults with a serious Staphylococcus aureus bloodstream infection. The main goal was to check if the combination is safe and tolerable. Fifty-six hospitalized adults took part, and researchers monitored side effects and signs of improvement over 12 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banner University Medical Center
Tucson, Arizona, 85719, United States
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
-
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Johns Hopkins University
Baltimore, Maryland, 21218, United States
-
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Torrance, California, 90502, United States
-
Methodist Hospital Research Institute - Houston
Houston, Texas, 77030, United States
-
Monash Health
Clayton, Australia
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Regional One Healthcare
Memphis, Tennessee, 38103, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
Rocky Mountain Regional VA Medical Center
Aurora, Colorado, 80045, United States
-
Royal Adelaide Hospital
Adelaide, Australia
-
Royal Melbourne Hospital
Melbourne, Australia
-
The Alfred Hospital
Melbourne, Australia
-
The Jamaica Hospital Medical Center
Jamaica, New York, 11418, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
University of California, Los Angeles (UCLA) - Medical Center
Los Angeles, California, 90095, United States
-
University of California, San Diego (UCSD) - Medical Center
La Jolla, California, 92037, United States
-
University of Florida (UF) - Division of Infectious Disease
Gainesville, Florida, 32610, United States
-
University of Florida - Jacksonville
Jacksonville, Florida, 32209, United States
-
University of Michigan
Ann Arbor, Michigan, 48103, United States
-
University of North Carolina - Chapel Hill School of Medicine
Chapel Hill, North Carolina, 27599, United States
-
University of South Florida
Tampa, Florida, 33620, United States
-
University of Southern California Keck School of Medicine
Los Angeles, California, 90033, United States
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
-
Westmead Hospital
Westmead, Australia
Conditions
Explore the condition pages connected to this study.